中华妇幼临床医学杂志(电子版)
中華婦幼臨床醫學雜誌(電子版)
중화부유림상의학잡지(전자판)
CHINESE JOURNAL OF OBSTETRICS & GYNECOLOGY AND PEDIATRICS(ELECTRONIC VERSION)
2014年
4期
469-472
,共4页
常瑛%张珩%宋艳%石晓琳
常瑛%張珩%宋豔%石曉琳
상영%장형%송염%석효림
围手术期%抗菌药%药师
圍手術期%抗菌藥%藥師
위수술기%항균약%약사
Perioperative period%Anti-bacterial agents%Pharmacists
目的:评价临床药师干预对剖宫产围手术期预防性使用抗菌药物的影响。方法选择2012年7月~9月在陕西省妇幼保健院行剖宫产手术未接受临床药师围手术期抗菌药物使用干预患者纳入未干预组(n=136),而对2013年7月~9月在同一家医院进行剖宫产手术后接受临床药师围手术期抗菌药物使用干预的患者纳入干预组(n=145)。对其采用回顾性分析方法,对围手术期预防性使用抗菌药物的合理性及住院情况进行比较(本研究遵循的程序符合陕西省妇幼保健院人体试验委员会制定的伦理学标准,得到该委员会批准,分组征得受试对象知情同意,并与之签署临床研究知情同意书)。两组患者平均年龄、手术时间及出血量比较,差异均无统计学意义(P>0.05)。结果经临床药师干预后,干预后组患者预防性使用抗菌药物在药物选择合理率及术后使用时间合理率方面较未干预前组有显著改善,且差异有统计学意义(χ2=6.30,221.38;P=0.01,0.00);两组用药时机合理率及平均住院时间比较,差异无统计学意义(χ2/t=1.36,1.60;P=0.24,0.11);两组人均抗菌药物费用、人均药品总费用及人均住院总费用比较,差异均有统计学意义(t=28.99,5.10,4.23;P=0.00,0.00,0.00)。结论经临床药师干预后,剖宫产手术围手术期对患者预防性使用抗菌药物的合理性有显著提高,减少了患者住院费用。临床药师对围手术期剖宫产患者进行抗菌药物使用干预的方法可行、有效。
目的:評價臨床藥師榦預對剖宮產圍手術期預防性使用抗菌藥物的影響。方法選擇2012年7月~9月在陝西省婦幼保健院行剖宮產手術未接受臨床藥師圍手術期抗菌藥物使用榦預患者納入未榦預組(n=136),而對2013年7月~9月在同一傢醫院進行剖宮產手術後接受臨床藥師圍手術期抗菌藥物使用榦預的患者納入榦預組(n=145)。對其採用迴顧性分析方法,對圍手術期預防性使用抗菌藥物的閤理性及住院情況進行比較(本研究遵循的程序符閤陝西省婦幼保健院人體試驗委員會製定的倫理學標準,得到該委員會批準,分組徵得受試對象知情同意,併與之籤署臨床研究知情同意書)。兩組患者平均年齡、手術時間及齣血量比較,差異均無統計學意義(P>0.05)。結果經臨床藥師榦預後,榦預後組患者預防性使用抗菌藥物在藥物選擇閤理率及術後使用時間閤理率方麵較未榦預前組有顯著改善,且差異有統計學意義(χ2=6.30,221.38;P=0.01,0.00);兩組用藥時機閤理率及平均住院時間比較,差異無統計學意義(χ2/t=1.36,1.60;P=0.24,0.11);兩組人均抗菌藥物費用、人均藥品總費用及人均住院總費用比較,差異均有統計學意義(t=28.99,5.10,4.23;P=0.00,0.00,0.00)。結論經臨床藥師榦預後,剖宮產手術圍手術期對患者預防性使用抗菌藥物的閤理性有顯著提高,減少瞭患者住院費用。臨床藥師對圍手術期剖宮產患者進行抗菌藥物使用榦預的方法可行、有效。
목적:평개림상약사간예대부궁산위수술기예방성사용항균약물적영향。방법선택2012년7월~9월재합서성부유보건원행부궁산수술미접수림상약사위수술기항균약물사용간예환자납입미간예조(n=136),이대2013년7월~9월재동일가의원진행부궁산수술후접수림상약사위수술기항균약물사용간예적환자납입간예조(n=145)。대기채용회고성분석방법,대위수술기예방성사용항균약물적합이성급주원정황진행비교(본연구준순적정서부합합서성부유보건원인체시험위원회제정적윤리학표준,득도해위원회비준,분조정득수시대상지정동의,병여지첨서림상연구지정동의서)。량조환자평균년령、수술시간급출혈량비교,차이균무통계학의의(P>0.05)。결과경림상약사간예후,간예후조환자예방성사용항균약물재약물선택합리솔급술후사용시간합리솔방면교미간예전조유현저개선,차차이유통계학의의(χ2=6.30,221.38;P=0.01,0.00);량조용약시궤합리솔급평균주원시간비교,차이무통계학의의(χ2/t=1.36,1.60;P=0.24,0.11);량조인균항균약물비용、인균약품총비용급인균주원총비용비교,차이균유통계학의의(t=28.99,5.10,4.23;P=0.00,0.00,0.00)。결론경림상약사간예후,부궁산수술위수술기대환자예방성사용항균약물적합이성유현저제고,감소료환자주원비용。림상약사대위수술기부궁산환자진행항균약물사용간예적방법가행、유효。
Objective To evaluate the effects of clinical pharmacist intervention on the use of antibacterials during perioperative period of cesarean section.Methods The patients with cesarean section who were not receive clinical pharmacist intervention on the use of antibacterials during perioperative period from July to September 2012 in Shaanxi Martenal and Child Hospital were chosen into non-intervention group(n=136).The patients with cesarean section who received clinical pharmacist intervention on the use of antibacterials during perioperative period from July to September 2013 in the same hospital were chosen into intervention group(n=145).The rationality of prophylactic use of antibacterials during perioperative period and effects of hospitalization were compared,retrospectively.The study protocol was approved by the Ethical Review Board of Investigation in Human Beings of Shaanxi Marternal and Child Hospital. Informed consent was obtained from each participating patient.The average age,operation duration and the amount of bleeding had no significant differences between two groups (P>0.05 ).Results After the intervention of clinical pharmacist,the rationality of choice of medicine and medication time of the preventive application of antibacterials during perioperative period were statistically improved compared with those of non-intervention(χ2 = 6.30,221.38;P=0.01,0.00 ).While the time points of prophylaxis use of antibacterials and mean hospital days had no significant differences between two groups(χ2/t=1.36,1.60;P=0.24,0.11).The per capita antibacterial expense,per capita total medicine expense and per capita total hospitalization expense were statistically lower after intervention(t=28.99,5.10,4.23;P=0.00,0.00, 0.00).Conclusions The rationality of use of antibacterials during perioperative period of cesarean section were significantly improved after clinical pharmacist intervention,which could reduce hospitalization expense.The clinical pharmacist intervention on the preventative application of antibacterials is feasible and effective.